Skip to main content
Hydrocolloid Dressing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Hydrocolloid Dressing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Published: Dec 2023 154 Pages SKU: IRTNTR77070

Market Overview at a Glance

$312.08 Mn
Market Opportunity
4.63%
CAGR
4.31
YoY growth 2023-2024(%)

Hydrocolloid Dressing Market Size 2024-2028

The hydrocolloid dressing market size is forecast to increase by USD 312.08 million at a CAGR of 4.63% between 2023 and 2028.

  • The market is experiencing significant growth due to the increasing incidence and prevalence of acute and chronic wounds worldwide. According to the World Health Organization, an estimated 6.5 million people require wound care each year, creating a substantial demand for advanced wound healing solutions. Hydrocolloid dressings, known for their ability to absorb exudate and maintain a moist wound healing environment, are gaining popularity in the healthcare industry. Moreover, the emergence of nanoparticles in hydrocolloid wound dressings is a notable trend in the market. These advanced dressings offer enhanced properties, such as improved adhesion, better moisture retention, and increased biocompatibility, making them an attractive option for healthcare professionals and patients alike.
  • However, the market is not without challenges. Inherent issues, such as the risk of skin irritation, potential for dressing detachment, and the need for frequent dressing changes, can impact patient compliance and overall market growth. Companies seeking to capitalize on market opportunities and navigate challenges effectively must focus on addressing these issues through product innovation and improved patient education.

What will be the Size of the Hydrocolloid Dressing Market during the forecast period?

Hydrocolloid Dressing Market Size

 Request Free Sample

  • The market encompasses a range of advanced wound care solutions designed to promote healing in various types of wounds, including miscellaneous burns, venous leg ulcers, pressure injuries, and acute wounds. These dressings employ hydrocolloid technology, which facilitates autolytic debridement and maintains a moist wound environment, enhancing the body's natural healing process. Hydrocolloid dressings are applicable to diverse wound categories, such as thermal burns, electrical burns, and trauma-induced injuries. The market's growth is driven by the increasing prevalence of chronic wounds, particularly in populations with diabetes and the aging demographic. Furthermore, the rising number of surgical procedures and road traffic crashes contribute to the market expansion.
  • Advanced wound care products, such as nonwoven hydrocolloid dressings and polyurethane films, are gaining popularity due to their ability to manage exudate and provide a protective barrier against bacterial infections. E-sources like eBMEDICINE and NCBI provide valuable insights into the latest research and developments in hydrocolloid dressing technology. Overall, the market is poised for continued growth, addressing the unmet needs of healthcare providers and patients alike.

How is this Hydrocolloid Dressing Industry segmented?

The hydrocolloid dressing industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • Application
    • Chronic wound
    • Acute wound
  • End-user
    • Hospitals
    • Clinics
    • Others
  • Geography
    • North America
      • US
    • Europe
      • Germany
      • UK
    • Asia
      • China
      • Japan
    • Rest of World (ROW)

    By Application Insights

    The chronic wound segment is estimated to witness significant growth during the forecast period.

    The market is driven by the significant demand for advanced wound care solutions, particularly for chronic wounds. According to , the chronic wound segment is expected to dominate the market due to the increasing global prevalence of chronic wounds, such as ulcers, traumatic wounds, and surgical wounds. Approximately 6.7 million people currently live with chronic wounds, and this number is projected to grow by more than two percent in the next decade. Moreover, both surgical incisions and traumatic wounds caused by accidents account for over 150 million cases annually, with road traffic accidents contributing to a rising number of injuries.

    Advanced wound care products, including hydrocolloid dressings, are essential for managing various types of wounds, such as SSIs (Surgical Site Infections), thermal burns, diabetic foot ulcers, and pressure injuries. Hydrocolloid dressings offer advantages like skin barrier protection, moisture retention, and autolytic debridement, making them an ideal choice for wound treatment. Additionally, they are suitable for various applications, including acute wounds, chronic wounds, and traumatic wounds. Absorbent dressings, transparent dressings, adhesive dressings, and hydrogel dressings are some popular types of hydrocolloid dressings. These dressings cater to diverse wound care needs, such as managing blood loss, providing thermal burn protection, and promoting skin healing solutions.

    In the healthcare supplies industry, companies like Smith & Nephew offer a wide range of hydrocolloid dressings for hospitals, home healthcare, and independent diabetes care. The market for hydrocolloid dressing materials also includes nonwovens, polyurethane films, and medical tape. These materials contribute to the production of various wound care products, including surgical wound care, ostomy care products, and pressure ulcer management solutions. Furthermore, hydrocolloid dressings are effective in treating miscellaneous burns, such as chemical burns and electric burns, making them an essential component of burn care. In summary, the market is expected to grow significantly due to the increasing demand for advanced wound care solutions for chronic and acute wounds, as well as trauma injuries.

    The market caters to various wound types, including SSIs, thermal burns, diabetic foot ulcers, and pressure injuries, using materials like nonwovens, polyurethane films, and medical tape. The market is driven by the rising global prevalence of chronic wounds and the growing number of surgical and traumatic wounds.

    Hydrocolloid Dressing Market Size

    Get a glance at the market report of share of various segments Request Free Sample

    The Chronic wound segment was valued at USD 660.60 million in 2018 and showed a gradual increase during the forecast period.

    Regional Analysis

    North America is estimated to contribute 41% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

    Hydrocolloid Dressing Market Share by Geography

    For more insights on the market size of various regions, Request Free Sample

    The market in North America is experiencing significant growth due to the rising prevalence of acute and chronic wounds, particularly among the geriatric population. Advanced wound care treatments, such as hydrocolloid and hydrogel dressings, are increasingly being adopted to promote skin barrier protection and skin healing solutions for various types of wounds, including SSIs, thermal burns, diabetic foot ulcers, and pressure injuries. The use of hydrocolloid dressings facilitates autolytic debridement and moist wound healing, making them an effective option for chronic wound management. Major revenue contributors to the North American the market include hospitals, home healthcare, and independent diabetes care.

    Leading companies, such as Smith & Nephew, offer a wide range of hydrocolloid dressing products for different wound types and sizes. The increasing adoption of advanced wound care technologies, such as transparent dressings, medical tape, and absorbent dressings, is further driving market growth. Moreover, the growing awareness of advanced wound care treatments and the availability of various wound dressing materials, including nonwovens and polyurethane films, are expected to provide significant opportunities for market expansion. The market in North America is expected to witness substantial growth during the forecast period, primarily due to the increasing number of surgical procedures, road traffic crashes, and ICU admissions resulting in acute and chronic wounds.

    Additionally, the rising prevalence of severe burn injuries and the availability of advanced wound care products, such as electric burn dressings and miscellaneous burn dressings, are further expected to fuel market growth. Overall, the market in North America is poised for expansion due to the increasing demand for effective wound care solutions and the strong presence of leading companies.

    Market Dynamics

    Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

    What are the key market drivers leading to the rise in the adoption of Hydrocolloid Dressing Industry?

    • Increasing incidence and prevalence of acute and chronic wounds is the key driver of the market. 

    • The rising prevalence of chronic and acute wounds, including diabetic foot ulcers, venous ulcers, pressure ulcers, burns, and traumatic ulcers, is driving the demand for hydrocolloid dressings. Diabetes, a global health concern, is a significant contributor to the increasing incidence of diabetic foot ulcers. Diabetic patients, due to poor blood circulation and neuropathy, are prone to developing blisters that can easily progress into ulcers, increasing the risk of infection. With the growing number of diabetic patients worldwide, the demand for hydrocolloid dressings is anticipated to rise.
    • These dressings provide an ideal environment for wound healing by maintaining a moist environment, promoting granulation, and preventing infection. The market for hydrocolloid dressings is expected to experience steady growth due to the increasing burden of chronic and acute wounds.

    What are the market trends shaping the Hydrocolloid Dressing Industry?

    • Emergence of nanoparticles to treat wounds is the upcoming market trend. 

    • Wound treatment is a critical field of research due to the skin's essential physiological and aesthetic functions. In recent years, nanoparticles have emerged as promising platforms for treating both acute and chronic wounds. Copper, silver, gold titanium, and zinc oxide nanoparticles have demonstrated therapeutic effects on wound healing. The unique properties of nanoparticles, such as solid lipid nanoparticles, nanocapsules, polymersomes, and polymeric nanocomplexes, make them excellent vehicles for enhancing the efficacy of drugs used in wound healing.
    • By incorporating nanoparticles into various pharmaceutical materials, the beneficial properties of formulations can be amplified, and better dose control can be achieved. These advancements offer significant potential for improving wound care treatments.

    What challenges does the Hydrocolloid Dressing Industry face during its growth?

    • Inherent challenges associated with hydrocolloid wound dressings is a key challenge affecting the industry growth. 

    • Hydrocolloid dressings are a popular choice in modern wound care due to their ability to maintain a moist environment and promote healing. These interactive dressings are widely used for various types of wounds, excluding neuropathic ulcers and highly exudative wounds. However, their use comes with certain complications and limitations. One such limitation is the potential for tissue damage in areas prone to friction. Additionally, hydrocolloid dressings can accumulate exudate, leading to maceration and bacterial proliferation, resulting in a foul smell.
    • Despite these challenges, hydrocolloid dressings remain a significant option in wound care, offering benefits such as maintaining an optimal moisture balance and protecting the wound from external factors. It is essential for healthcare professionals to consider the specific needs of each patient and the type of wound before selecting a dressing to ensure optimal healing and minimize potential complications.

    Exclusive Customer Landscape

    The hydrocolloid dressing market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the hydrocolloid dressing market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

    Hydrocolloid Dressing Market Share by Geography

     Customer Landscape

    Key Companies & Market Insights

    Companies are implementing various strategies, such as strategic alliances, hydrocolloid dressing market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

    3M Co. - Hydrocolloid dressings, including 3M Tegaderm, deliver a superior moisture vapor transmission rate, thereby minimizing the risk of shear and friction. These advanced wound coverings optimize healing environments by maintaining a moist wound condition while preventing maceration. The consistent transmission of moisture vapor facilitates the exchange of gases and promotes a healthy wound microclimate. By reducing friction and shear forces, hydrocolloid dressings protect the delicate tissue from damage, ultimately enhancing the overall effectiveness of the wound care treatment.

    The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

    • 3M Co.
    • AMERX Health Care Corp.
    • B.Braun SE
    • Cardinal Health Inc.
    • ConvaTec Group Plc
    • Covalon Technologies Ltd.
    • DermaRite Industries LLC
    • Essity AB
    • Hollister Inc.
    • Integra Lifesciences Corp.
    • Johnson and Johnson
    • Lohmann and Rauscher GmbH and Co. KG
    • McKesson Corp.
    • Medline Industries LP
    • Medtronic Plc
    • Molnlycke Health Care AB
    • Paul Hartmann AG
    • Roosin Medical Co. Ltd 
    • Smith and Nephew plc
    • Coloplast AS

    Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

    Research Analyst Overview

    The market encompasses a broad range of advanced wound care solutions, with hydrocolloids being a prominent type. These dressings are characterized by their ability to absorb exudate and maintain a moist wound environment, promoting autolytic debridement and enhancing the healing process. Hydrocolloid dressings are particularly effective in managing various types of wounds, including those in the geriatric population, diabetic foot ulcers, and thermal burns. Advanced dressings, including hydrocolloids, have gained significant traction in healthcare settings due to their superior capabilities compared to traditional absorbent dressings. Hospitals and home healthcare providers increasingly rely on these advanced wound care solutions for acute and chronic wound treatment.

    Surgical wound care and pressure ulcer management are among the primary applications for hydrocolloid dressings. The market caters to diverse wound types, such as miscellaneous burns, electrical burns, and road traffic crash injuries. These dressings offer skin barrier protection and facilitate skin healing solutions, making them essential in Intensive Care Unit (ICU) settings for severe burn injuries. Hydrocolloid dressings are available in various forms, including transparent options, which enable continuous monitoring of the wound healing process. Adhesive dressings, medical tape, and polyurethane films are alternative wound dressing materials used in conjunction with hydrocolloids for optimal wound management. The market for hydrocolloid dressings is driven by the increasing prevalence of chronic wounds and the growing need for effective wound care solutions.

    The aging population and the rising incidence of diabetes contribute significantly to the demand for advanced wound care products. The market is expected to grow steadily due to ongoing research and development efforts aimed at improving the efficacy and functionality of hydrocolloid dressings. Healthcare suppliers offer a wide range of hydrocolloid dressing products to cater to diverse wound care needs. Smith & Nephew, for instance, is a leading player in the market, providing innovative wound care solutions. Other market participants focus on niche applications, such as ostomy care products and surgical procedures. In summary, the market represents a dynamic and growing segment of the advanced wound care industry.

    These dressings offer numerous benefits, including exudate management, skin barrier protection, and enhanced wound healing. The market is driven by the increasing prevalence of chronic wounds and the aging population, with ongoing research and development efforts contributing to its growth.

    Market Scope

    Report Coverage

    Details

    Page number

    154

    Base year

    2023

    Historic period

    2018-2022

    Forecast period

    2024-2028

    Growth momentum & CAGR

    Accelerate at a CAGR of 4.63%

    Market growth 2024-2028

    USD 312.08 million

    Market structure

    Fragmented

    YoY growth 2023-2024(%)

    4.31

    Key countries

    US, Germany, UK, China, and Japan

    Competitive landscape

    Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

    Request Free Sample

    What are the Key Data Covered in this Hydrocolloid Dressing Market Research and Growth Report?

    • CAGR of the Hydrocolloid Dressing industry during the forecast period
    • Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
    • Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
    • Accurate predictions about upcoming growth and trends and changes in consumer behaviour
    • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
    • Thorough analysis of the market’s competitive landscape and detailed information about companies
    • Comprehensive analysis of factors that will challenge the hydrocolloid dressing market growth of industry companies

    We can help! Our analysts can customize this hydrocolloid dressing market research report to meet your requirements.

    Get in touch

     

    1 Executive Summary

    • 1.1 Market overview
      • Exhibit 01: Executive Summary – Chart on Market Overview
      • Exhibit 02: Executive Summary – Data Table on Market Overview
      • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
      • Exhibit 04: Executive Summary – Chart on Market by Geography
      • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
      • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
      • Exhibit 07: Executive Summary – Chart on Incremental Growth
      • Exhibit 08: Executive Summary – Data Table on Incremental Growth
      • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

    2 Market Landscape

    • 2.1 Market ecosystem
      • Exhibit 10: Parent market
      • Exhibit 11: Market Characteristics

    3 Market Sizing

    • 3.1 Market definition
      • Exhibit 12: Offerings of vendors included in the market definition
    • 3.2 Market segment analysis
      • Exhibit 13: Market segments
    • 3.3 Market size 2023
      • 3.4 Market outlook: Forecast for 2023-2028
        • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
        • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
        • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
        • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

      4 Historic Market Size

      • 4.1 Global hydrocolloid dressing market 2018 - 2022
        • Exhibit 18: Historic Market Size – Data Table on global hydrocolloid dressing market 2018 - 2022 ($ million)
      • 4.2 Application Segment Analysis 2018 - 2022
        • Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ million)
      • 4.3 End-user Segment Analysis 2018 - 2022
        • Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
      • 4.4 Geography Segment Analysis 2018 - 2022
        • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
      • 4.5 Country Segment Analysis 2018 - 2022
        • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

      5 Five Forces Analysis

      • 5.1 Five forces summary
        • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
      • 5.2 Bargaining power of buyers
        • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
      • 5.3 Bargaining power of suppliers
        • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
      • 5.4 Threat of new entrants
        • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
      • 5.5 Threat of substitutes
        • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
      • 5.6 Threat of rivalry
        • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
      • 5.7 Market condition
        • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

      6 Market Segmentation by Application

      • 6.1 Market segments
        • Exhibit 30: Chart on Application - Market share 2023-2028 (%)
        • Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
      • 6.2 Comparison by Application
        • Exhibit 32: Chart on Comparison by Application
        • Exhibit 33: Data Table on Comparison by Application
      • 6.3 Chronic wound - Market size and forecast 2023-2028
        • Exhibit 34: Chart on Chronic wound - Market size and forecast 2023-2028 ($ million)
        • Exhibit 35: Data Table on Chronic wound - Market size and forecast 2023-2028 ($ million)
        • Exhibit 36: Chart on Chronic wound - Year-over-year growth 2023-2028 (%)
        • Exhibit 37: Data Table on Chronic wound - Year-over-year growth 2023-2028 (%)
      • 6.4 Acute wound - Market size and forecast 2023-2028
        • Exhibit 38: Chart on Acute wound - Market size and forecast 2023-2028 ($ million)
        • Exhibit 39: Data Table on Acute wound - Market size and forecast 2023-2028 ($ million)
        • Exhibit 40: Chart on Acute wound - Year-over-year growth 2023-2028 (%)
        • Exhibit 41: Data Table on Acute wound - Year-over-year growth 2023-2028 (%)
      • 6.5 Market opportunity by Application
        • Exhibit 42: Market opportunity by Application ($ million)
        • Exhibit 43: Data Table on Market opportunity by Application ($ million)

      7 Market Segmentation by End-user

      • 7.1 Market segments
        • Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
        • Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
      • 7.2 Comparison by End-user
        • Exhibit 46: Chart on Comparison by End-user
        • Exhibit 47: Data Table on Comparison by End-user
      • 7.3 Hospitals - Market size and forecast 2023-2028
        • Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
        • Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
        • Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
        • Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
      • 7.4 Clinics - Market size and forecast 2023-2028
        • Exhibit 52: Chart on Clinics - Market size and forecast 2023-2028 ($ million)
        • Exhibit 53: Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
        • Exhibit 54: Chart on Clinics - Year-over-year growth 2023-2028 (%)
        • Exhibit 55: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
      • 7.5 Others - Market size and forecast 2023-2028
        • Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
        • Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
        • Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
        • Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
      • 7.6 Market opportunity by End-user
        • Exhibit 60: Market opportunity by End-user ($ million)
        • Exhibit 61: Data Table on Market opportunity by End-user ($ million)

      8 Customer Landscape

      • 8.1 Customer landscape overview
        • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

      9 Geographic Landscape

      • 9.1 Geographic segmentation
        • Exhibit 63: Chart on Market share by geography 2023-2028 (%)
        • Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
      • 9.2 Geographic comparison
        • Exhibit 65: Chart on Geographic comparison
        • Exhibit 66: Data Table on Geographic comparison
      • 9.3 North America - Market size and forecast 2023-2028
        • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
        • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
        • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
        • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
      • 9.4 Europe - Market size and forecast 2023-2028
        • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
        • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
        • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
        • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
      • 9.5 Asia - Market size and forecast 2023-2028
        • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
        • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
        • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
        • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
      • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
        • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
        • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
        • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
        • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • 9.7 US - Market size and forecast 2023-2028
        • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
        • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
        • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
        • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
      • 9.8 Germany - Market size and forecast 2023-2028
        • Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
        • Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
        • Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
        • Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
      • 9.9 UK - Market size and forecast 2023-2028
        • Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
        • Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
        • Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
        • Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
      • 9.10 China - Market size and forecast 2023-2028
        • Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
        • Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
        • Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
        • Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
      • 9.11 Japan - Market size and forecast 2023-2028
        • Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
        • Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
        • Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
        • Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
      • 9.12 Market opportunity by geography
        • Exhibit 103: Market opportunity by geography ($ million)
        • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

      10 Drivers, Challenges, and Trends

      • 10.1 Market drivers
        • 10.2 Market challenges
          • 10.3 Impact of drivers and challenges
            • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
          • 10.4 Market trends

            11 Vendor Landscape

            • 11.1 Overview
              • 11.2 Vendor landscape
                • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
              • 11.3 Landscape disruption
                • Exhibit 107: Overview on factors of disruption
              • 11.4 Industry risks
                • Exhibit 108: Impact of key risks on business

              12 Vendor Analysis

              • 12.1 Vendors covered
                • Exhibit 109: Vendors covered
              • 12.2 Market positioning of vendors
                • Exhibit 110: Matrix on vendor position and classification
              • 12.3 3M Co.
                • Exhibit 111: 3M Co. - Overview
                • Exhibit 112: 3M Co. - Business segments
                • Exhibit 113: 3M Co. - Key news
                • Exhibit 114: 3M Co. - Key offerings
                • Exhibit 115: 3M Co. - Segment focus
              • 12.4 AMERX Health Care Corp.
                • Exhibit 116: AMERX Health Care Corp. - Overview
                • Exhibit 117: AMERX Health Care Corp. - Product / Service
                • Exhibit 118: AMERX Health Care Corp. - Key offerings
              • 12.5 B.Braun SE
                • Exhibit 119: B.Braun SE - Overview
                • Exhibit 120: B.Braun SE - Business segments
                • Exhibit 121: B.Braun SE - Key news
                • Exhibit 122: B.Braun SE - Key offerings
                • Exhibit 123: B.Braun SE - Segment focus
              • 12.6 Cardinal Health Inc.
                • Exhibit 124: Cardinal Health Inc. - Overview
                • Exhibit 125: Cardinal Health Inc. - Business segments
                • Exhibit 126: Cardinal Health Inc. - Key news
                • Exhibit 127: Cardinal Health Inc. - Key offerings
                • Exhibit 128: Cardinal Health Inc. - Segment focus
              • 12.7 Coloplast AS
                • Exhibit 129: Coloplast AS - Overview
                • Exhibit 130: Coloplast AS - Business segments
                • Exhibit 131: Coloplast AS - Key news
                • Exhibit 132: Coloplast AS - Key offerings
                • Exhibit 133: Coloplast AS - Segment focus
              • 12.8 ConvaTec Group Plc
                • Exhibit 134: ConvaTec Group Plc - Overview
                • Exhibit 135: ConvaTec Group Plc - Business segments
                • Exhibit 136: ConvaTec Group Plc - Key offerings
                • Exhibit 137: ConvaTec Group Plc - Segment focus
              • 12.9 Covalon Technologies Ltd.
                • Exhibit 138: Covalon Technologies Ltd. - Overview
                • Exhibit 139: Covalon Technologies Ltd. - Product / Service
                • Exhibit 140: Covalon Technologies Ltd. - Key offerings
              • 12.10 DermaRite Industries LLC
                • Exhibit 141: DermaRite Industries LLC - Overview
                • Exhibit 142: DermaRite Industries LLC - Product / Service
                • Exhibit 143: DermaRite Industries LLC - Key offerings
              • 12.11 Essity AB
                • Exhibit 144: Essity AB - Overview
                • Exhibit 145: Essity AB - Business segments
                • Exhibit 146: Essity AB - Key offerings
                • Exhibit 147: Essity AB - Segment focus
              • 12.12 Hollister Inc.
                • Exhibit 148: Hollister Inc. - Overview
                • Exhibit 149: Hollister Inc. - Product / Service
                • Exhibit 150: Hollister Inc. - Key offerings
              • 12.13 Integra Lifesciences Corp.
                • Exhibit 151: Integra Lifesciences Corp. - Overview
                • Exhibit 152: Integra Lifesciences Corp. - Business segments
                • Exhibit 153: Integra Lifesciences Corp. - Key news
                • Exhibit 154: Integra Lifesciences Corp. - Key offerings
                • Exhibit 155: Integra Lifesciences Corp. - Segment focus
              • 12.14 Johnson and Johnson
                • Exhibit 156: Johnson and Johnson - Overview
                • Exhibit 157: Johnson and Johnson - Business segments
                • Exhibit 158: Johnson and Johnson - Key news
                • Exhibit 159: Johnson and Johnson - Key offerings
                • Exhibit 160: Johnson and Johnson - Segment focus
              • 12.15 Lohmann and Rauscher GmbH and Co. KG
                • Exhibit 161: Lohmann and Rauscher GmbH and Co. KG - Overview
                • Exhibit 162: Lohmann and Rauscher GmbH and Co. KG - Product / Service
                • Exhibit 163: Lohmann and Rauscher GmbH and Co. KG - Key offerings
              • 12.16 McKesson Corp.
                • Exhibit 164: McKesson Corp. - Overview
                • Exhibit 165: McKesson Corp. - Business segments
                • Exhibit 166: McKesson Corp. - Key offerings
                • Exhibit 167: McKesson Corp. - Segment focus
              • 12.17 Medline Industries LP
                • Exhibit 168: Medline Industries LP - Overview
                • Exhibit 169: Medline Industries LP - Product / Service
                • Exhibit 170: Medline Industries LP - Key offerings

              13 Appendix

              • 13.1 Scope of the report
                • 13.2 Inclusions and exclusions checklist
                  • Exhibit 171: Inclusions checklist
                  • Exhibit 172: Exclusions checklist
                • 13.3 Currency conversion rates for US$
                  • Exhibit 173: Currency conversion rates for US$
                • 13.4 Research methodology
                  • Exhibit 174: Research methodology
                  • Exhibit 175: Validation techniques employed for market sizing
                  • Exhibit 176: Information sources
                • 13.5 List of abbreviations
                  • Exhibit 177: List of abbreviations

                Research Methodology

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                INFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases

                DATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts

                REPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape

                Interested in this report?

                Get your sample now to see our research methodology and insights!

                Download Now

                Frequently Asked Questions

                Hydrocolloid Dressing market growth will increase by $ 312.08 mn during 2024-2028 .

                The Hydrocolloid Dressing market is expected to grow at a CAGR of 4.63% during 2024-2028 .

                Hydrocolloid Dressing market is segmented by Application( Chronic wound, Acute wound) End-user( Hospitals, Clinics, Others)

                3M Co., AMERX Health Care Corp., B.Braun SE, Cardinal Health Inc., ConvaTec Group Plc, Covalon Technologies Ltd., DermaRite Industries LLC, Essity AB, Hollister Inc., Integra Lifesciences Corp., Johnson and Johnson, Lohmann and Rauscher GmbH and Co. KG, McKesson Corp., Medline Industries LP, Medtronic Plc, Molnlycke Health Care AB, Paul Hartmann AG, Roosin Medical Co. Ltd , Smith and Nephew plc, Coloplast AS are a few of the key vendors in the Hydrocolloid Dressing market.

                North America will register the highest growth rate of 41% among the other regions. Therefore, the Hydrocolloid Dressing market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

                US, Germany, UK, China, Japan

                • Increasing incidence and prevalence of acute and chronic woundsThe increasing incidence and prevalence of acute and chronic wounds are expected to increase the demand for hydrocolloid dressings. Both chronic and acute wounds is the driving factor this market.
                • such as diabetic foot ulcers is the driving factor this market.
                • venous ulcers is the driving factor this market.
                • pressure ulcers is the driving factor this market.
                • burns is the driving factor this market.
                • and traumatic ulcers is the driving factor this market.
                • require moist wound dressings. The market has witnessed an increase in the incidence of the abovementioned types of wounds. Diabetes is associated with several serious complications. One of them is diabetic foot ulcers. Because of poor blood circulation and neuropathy in the feet is the driving factor this market.
                • diabetic patients have the tendency to develop blisters is the driving factor this market.
                • which can easily turn into ulcers that become infected. The prevalence of diabetes mellitus is expected to increase globally is the driving factor this market.
                • and the number of diabetic patients is on the rise across the world. According to the data stated by The World Bank Group is the driving factor this market.
                • in 2020 is the driving factor this market.
                • the percentage prevalence of diabetes among the population aged 20-79 years in Canada is the driving factor this market.
                • China is the driving factor this market.
                • India is the driving factor this market.
                • and the US was 7.7% is the driving factor this market.
                • 10.6% is the driving factor this market.
                • 10.4% is the driving factor this market.
                • and 10.7% is the driving factor this market.
                • respectively. Therefore is the driving factor this market.
                • due to the rise in the prevalence of diabetes is the driving factor this market.
                • the global prevalence of related complications such as diabetic foot has also increased. Furthermore is the driving factor this market.
                • most of the deaths due to burns occur in low- and middle-income countries is the driving factor this market.
                • including those in Southeast Asia. Burn injuries are highly prevalent in Bangladesh is the driving factor this market.
                • India is the driving factor this market.
                • and Nepal. For instance is the driving factor this market.
                • according to the CDC is the driving factor this market.
                • each year is the driving factor this market.
                • 1.1 million people who suffer burn injuries require medical attention in the US. Similarly is the driving factor this market.
                • pressure ulcers is the driving factor this market.
                • also called bedsores is the driving factor this market.
                • generally occur in an area with localized damage to the skin and underlying tissue as a result of pressure and friction. Pressure ulcers remain one of the major health problems globally. Hence is the driving factor this market.
                • the increase in the incidence of acute and chronic wounds is expected to drive the growth of the global hydrocolloid dressing market during the forecast period is the driving factor this market.

                The Hydrocolloid Dressing market vendors should focus on grabbing business opportunities from the Chronic wound segment as it accounted for the largest market share in the base year.